Then, we found that KLF6-SV1 knockdown inhibited cell proliferation, migration, and invasion, promoted cell apoptosis, and regulated the P21/CCND1 pathway in osteosarcoma, which was in line with previous studies regarding the effect of KLF6-SV1 in other cancers. Here, CCND1 is linked to osteosarcoma.